Last reviewed · How we verify
anti-GD2-800CW
At a glance
| Generic name | anti-GD2-800CW |
|---|---|
| Sponsor | Princess Maxima Center for Pediatric Oncology |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- anti-GD2-800CW CI brief — competitive landscape report
- anti-GD2-800CW updates RSS · CI watch RSS
- Princess Maxima Center for Pediatric Oncology portfolio CI